Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",27886,103,2.04 [1.18-3.54],0.0110942651231279
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",28471,148,1.08 [0.68-1.72],0.737027349650965
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",28214,1013,1.01 [0.85-1.20],0.9164632580304798
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Candidiasis,28504,311,0.96 [0.70-1.33],0.8171664170501796
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,27703,2799,1.03 [0.92-1.14],0.6182836371006719
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),27952,2108,1.11 [0.98-1.26],0.0868769177547263
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,28287,1007,1.17 [0.98-1.40],0.0830170274053264
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,28413,43,1.95 [0.83-4.57],0.1273255746123944
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,27216,652,0.97 [0.77-1.21],0.7707424610964586
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,26312,625,1.27 [1.02-1.60],0.0355247446024703
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,26563,174,1.44 [0.94-2.21],0.0978415395443203
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,21238,1226,1.09 [0.92-1.28],0.3147470685614217
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,26319,287,1.42 [1.02-1.99],0.0386690100448712
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,28455,1175,1.08 [0.92-1.28],0.3443771270253513
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Mycoses,28566,373,0.96 [0.71-1.28],0.757327683398817
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,27814,613,1.06 [0.84-1.33],0.6132925373000028
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,28500,717,1.03 [0.84-1.27],0.769091337063819
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,27430,150,1.00 [0.63-1.59],0.992063300111908
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,28607,33,1.65 [0.62-4.36],0.3139779681527377
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other septicaemia,28414,631,0.95 [0.76-1.19],0.6404608246537418
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,28445,75,1.15 [0.60-2.20],0.6718515427881957
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other viral diseases,28511,173,1.80 [1.17-2.76],0.0069804060915846
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",28496,158,1.83 [1.17-2.87],0.0081627306671238
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,27542,341,0.95 [0.70-1.29],0.7390573381160811
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,27449,248,0.97 [0.68-1.39],0.878329117246329
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,27363,83,0.83 [0.44-1.53],0.542155556719278
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,28579,54,1.25 [0.59-2.65],0.5528993923416377
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,28543,133,1.20 [0.73-1.95],0.4744805237423284
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Viral warts,28455,45,2.29 [1.00-5.23],0.0493800319360185
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],28461,51,0.53 [0.24-1.17],0.1145702922463595
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign lipomatous neoplasm,28307,324,0.89 [0.65-1.22],0.4726141910848551
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,28513,77,0.54 [0.28-1.02],0.0577684271264202
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,28491,82,1.09 [0.58-2.02],0.7940782647719088
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,12765,44,0.96 [0.41-2.20],0.9151477054861596
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",28407,1211,0.82 [0.70-0.96],0.014910803793604
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm of meninges,28595,49,0.53 [0.24-1.19],0.1263762808458975
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,28570,51,0.86 [0.39-1.88],0.6998568326736674
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,28584,93,1.21 [0.67-2.16],0.5273582790085813
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm of ovary,15778,101,0.91 [0.52-1.62],0.7578841211789892
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Ascending colon,28600,285,0.94 [0.67-1.31],0.7028216905755873
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Caecum,28596,211,0.80 [0.54-1.17],0.2463635968666462
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",28536,60,1.15 [0.56-2.36],0.7121070427012174
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Descending colon,28599,179,0.73 [0.48-1.11],0.1419061953306725
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Rectum,28562,298,0.78 [0.56-1.08],0.1342368971838985
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,28530,554,0.76 [0.60-0.96],0.0234222554417348
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Transverse colon,28600,322,0.72 [0.53-0.98],0.0383335147932936
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Carcinoma in situ of breast,13577,89,0.73 [0.40-1.35],0.3218946783206794
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",13626,102,0.51 [0.29-0.90],0.0194974310063457
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",24721,31,0.65 [0.24-1.80],0.4121797696547752
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",24729,39,1.82 [0.74-4.48],0.1914555615490689
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",28565,112,0.70 [0.41-1.19],0.1869390665625708
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Haemangioma, any site",28565,110,0.72 [0.42-1.24],0.2416784725295465
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Leiomyoma of uterus,15124,428,0.87 [0.66-1.15],0.3415670465541816
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Lung cancer and mesothelioma,21261,180,0.45 [0.29-0.68],0.0001569626488841
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Lymphoid leukaemia,24719,29,0.66 [0.23-1.90],0.445170076977875
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",24843,153,1.19 [0.75-1.89],0.4683468924671764
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",24776,86,1.04 [0.57-1.92],0.8932457907238622
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",13681,85,1.75 [0.94-3.26],0.0755299344180095
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",24742,52,1.05 [0.48-2.28],0.909079155932661
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",24759,69,1.47 [0.74-2.89],0.2699219096971217
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",24762,72,0.76 [0.39-1.48],0.4276055019254655
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",13653,57,1.14 [0.53-2.45],0.7274898605386524
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",24746,56,1.05 [0.50-2.23],0.8919792940672769
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",11520,426,0.99 [0.76-1.30],0.9642709991567282
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",24783,93,1.59 [0.89-2.85],0.11942416757202
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",24747,57,1.18 [0.56-2.50],0.6628952627383313
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,24755,65,1.11 [0.54-2.25],0.7788297016342786
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Melanocytic naevi,28360,221,0.86 [0.59-1.27],0.4526488813076701
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Melanocytic naevi of trunk,28555,98,0.55 [0.31-0.97],0.0389033363844965
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Melanoma in situ,24707,53,0.64 [0.29-1.41],0.2655140884660038
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",24751,61,1.35 [0.66-2.77],0.4161606223844684
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",24812,122,1.08 [0.65-1.81],0.7574285823363487
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",24811,121,0.43 [0.26-0.72],0.0013703785332103
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",24758,68,1.23 [0.62-2.45],0.5479902030104837
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Other benign neoplasms of skin,28420,147,0.94 [0.59-1.50],0.7954311889425968
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",25354,664,1.20 [0.96-1.50],0.1028471104579129
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",25386,696,1.18 [0.95-1.46],0.137673145524606
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,28327,292,0.92 [0.66-1.29],0.6338508607904936
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,27148,59,9.12 [4.64-17.94],1.4617403055242472e-10
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,28107,72,0.75 [0.39-1.45],0.3908075749640276
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,27781,2298,1.04 [0.93-1.17],0.4928844843994263
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,27384,25,2.45 [0.81-7.41],0.1127928180399474
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,28244,37,1.54 [0.62-3.83],0.3493116633854211
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,28150,1061,1.13 [0.95-1.34],0.1780884444835365
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,28150,1061,1.13 [0.95-1.34],0.1780884444835365
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,27148,59,3.18 [1.54-6.54],0.0016998125743081
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,28314,955,1.20 [1.00-1.44],0.0483919227155421
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,28322,115,1.61 [0.95-2.72],0.0754731058893734
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,28090,55,0.87 [0.41-1.85],0.7149921836528795
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,28078,43,1.05 [0.45-2.48],0.9061815460924654
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,28406,199,1.22 [0.82-1.81],0.3323447272953439
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,28527,72,0.94 [0.49-1.83],0.8648873763362326
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",28373,166,1.36 [0.88-2.10],0.1696837701491212
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,27435,76,0.56 [0.29-1.07],0.0815545196365742
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,24594,217,1.04 [0.71-1.53],0.8304356850943346
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,26627,130,0.32 [0.20-0.53],6.063886234730039e-06
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,26640,143,0.32 [0.20-0.51],1.4042591734055025e-06
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,24415,38,0.45 [0.18-1.12],0.0854364001876606
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,26572,72,1.10 [0.57-2.13],0.7685658182498858
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,26223,152,0.74 [0.46-1.16],0.1885374092749375
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",28458,174,0.86 [0.56-1.31],0.4753542666089837
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,28332,48,1.75 [0.78-3.96],0.17760496704499
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,28322,38,1.01 [0.40-2.53],0.9802767681643716
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,28187,1687,0.79 [0.69-0.91],0.0008156931066297
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,25633,1638,0.78 [0.68-0.89],0.0004159623467364
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",24418,41,0.78 [0.32-1.90],0.5845368692854351
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",26871,58,1.68 [0.80-3.53],0.1685410616580769
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,24569,192,1.65 [1.10-2.49],0.016410771174462
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,24443,66,1.09 [0.54-2.21],0.8114609868407138
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,26836,2459,0.83 [0.74-0.93],0.0016409025131954
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,24499,122,0.85 [0.51-1.42],0.53425505169949
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,24776,399,1.20 [0.90-1.59],0.213422615327315
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,28503,281,1.78 [1.27-2.49],0.0007736208068721
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,28335,113,4.25 [2.54-7.13],4.0109551031799495e-08
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,24477,100,0.99 [0.56-1.74],0.9668681247338275
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",24417,40,2.03 [0.83-4.97],0.1223633415258621
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,28163,1350,1.08 [0.92-1.26],0.3336646902453757
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,24509,132,2.00 [1.23-3.27],0.0055967702255539
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,24544,167,2.50 [1.62-3.86],3.4869906957363426e-05
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",24775,398,1.01 [0.76-1.34],0.9508122702172432
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,24439,62,0.98 [0.48-2.01],0.963702936838854
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,28328,106,4.94 [2.91-8.40],3.6326723792839005e-09
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,24683,306,1.12 [0.81-1.55],0.4945555986177654
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,24681,304,0.83 [0.60-1.15],0.259402860344767
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,26131,60,1.98 [0.97-4.05],0.0624997257680033
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,27896,3519,0.85 [0.78-0.94],0.0010846864291288
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,26850,37,1.84 [0.73-4.68],0.1979766095847073
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,26874,61,0.90 [0.43-1.86],0.7691637693895086
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,28420,1984,0.86 [0.76-0.98],0.0199981209441655
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",28424,1981,0.86 [0.76-0.98],0.0208313506755286
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,26852,39,1.37 [0.55-3.39],0.4969948688786098
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,28273,1278,0.81 [0.69-0.95],0.0080377343172853
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",25295,918,1.01 [0.83-1.21],0.9538016224714952
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,28597,137,1.81 [1.13-2.90],0.0133200855989332
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,28318,34,0.39 [0.15-1.01],0.0519492370409686
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,27086,91,0.98 [0.54-1.77],0.9439366050367574
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,27114,119,0.70 [0.42-1.17],0.1759198145956887
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",24513,136,1.14 [0.70-1.87],0.5999348991495694
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,26760,124,1.96 [1.19-3.23],0.0081159962686022
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1759,71,1.07 [0.56-2.04],0.8358127523670837
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1868,195,1.49 [1.02-2.18],0.0381545153985149
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,26677,41,0.72 [0.31-1.71],0.4596405556821392
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1725,37,5.63 [2.44-13.01],5.1452310076508017e-05
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,28178,1542,0.96 [0.83-1.11],0.5858674737592833
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,28358,74,1.01 [0.53-1.94],0.9800323433954692
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,26349,278,0.80 [0.57-1.12],0.1960412787089289
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,24795,418,1.45 [1.10-1.91],0.008443521403829
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",28517,181,1.83 [1.21-2.77],0.0040544645189909
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),27858,57,1.22 [0.59-2.55],0.5943419881176859
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Angina pectoris,27300,815,0.94 [0.77-1.14],0.5177872330533764
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Aortic aneurysm,27905,104,0.90 [0.52-1.56],0.7036012753301157
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,27831,30,1.13 [0.41-3.08],0.8172162189281825
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",27908,107,1.07 [0.62-1.84],0.8034801431402598
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,20430,970,0.84 [0.70-1.01],0.061367791795779
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,AV-block,26045,185,1.15 [0.76-1.74],0.522196875141453
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",28574,268,1.58 [1.12-2.23],0.0085496435758103
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Cardiac arrest,19578,118,1.32 [0.78-2.24],0.3069657068953903
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Cardiomyopathy,25996,136,0.57 [0.35-0.93],0.0234868295905268
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",25941,81,0.57 [0.30-1.06],0.075892021529444
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,28609,20,0.47 [0.14-1.62],0.232634094172654
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Conduction disorders,26402,542,0.97 [0.76-1.24],0.821434434804413
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,27868,1394,0.94 [0.81-1.10],0.4421718963572955
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,26611,6228,0.81 [0.76-0.87],1.7922354814653366e-08
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,DVT of lower extremities,27409,190,1.81 [1.21-2.71],0.0039587379676038
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Endocarditis,25904,44,2.64 [1.13-6.16],0.024791841431362
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Heart failure, strict",28488,528,0.71 [0.56-0.90],0.0055683624188419
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Hypertension,27209,5075,0.78 [0.72-0.84],1.1725983472289836e-09
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Hypertension, essential",27225,5091,0.79 [0.73-0.86],1.599465947943542e-08
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Hypertension, portal",28434,60,1.19 [0.58-2.43],0.6438654640133383
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",22223,89,1.14 [0.62-2.10],0.6658297365935094
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,22196,62,41.54 [21.82-79.06],7.581577712500225e-30
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Hypotension,28501,711,1.08 [0.88-1.34],0.4562600754654049
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,28064,65,0.72 [0.36-1.44],0.348942020414147
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",28033,1548,0.93 [0.80-1.07],0.2994824393092292
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",28372,314,0.87 [0.64-1.20],0.3997139491804801
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Left bundle-branch block,26057,197,0.82 [0.55-1.23],0.331941835196182
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,28340,611,1.14 [0.91-1.43],0.2433593023489652
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",26982,497,1.23 [0.96-1.59],0.1018767598848388
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",28549,122,1.40 [0.85-2.32],0.1851089944546615
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",28592,209,1.06 [0.72-1.56],0.7785636044113575
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Oesophageal varices,27261,42,1.60 [0.67-3.80],0.2855016540147279
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other aneurysm,27852,51,1.57 [0.72-3.43],0.2612405480584751
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other arrhythmias,26109,249,0.88 [0.61-1.26],0.469581851013731
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,27866,65,1.22 [0.62-2.43],0.5657535522581821
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,27948,147,1.54 [0.98-2.45],0.0638851501760092
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,25992,132,1.14 [0.70-1.87],0.6029187120800265
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other disorders of veins,27295,76,0.99 [0.52-1.89],0.98040835149155
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,27269,50,1.87 [0.85-4.12],0.1213100185819289
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,27811,39,0.37 [0.15-0.90],0.0288208182188662
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,27314,95,0.55 [0.31-0.98],0.0409755164408441
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,26458,598,1.10 [0.87-1.38],0.4260075712027841
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,27837,47,2.06 [0.91-4.64],0.0815338047487671
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,28149,348,0.95 [0.71-1.29],0.7584448324788533
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,28151,161,0.83 [0.54-1.29],0.4158032088227205
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",28014,242,0.90 [0.63-1.29],0.5554480121371748
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,19717,257,0.99 [0.69-1.42],0.951715077761256
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Peripheral artery disease,27984,210,0.91 [0.62-1.34],0.6399388543684733
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),27482,263,1.63 [1.15-2.30],0.0057628480484322
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Pulmonary embolism,28337,347,1.30 [0.96-1.75],0.0915015810869818
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,28566,337,0.89 [0.66-1.21],0.4722839591532078
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Right bundle-branch block,26039,179,0.92 [0.60-1.40],0.6839741168910579
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Secondary right heart disease,28147,157,0.84 [0.54-1.31],0.4453653491553133
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,27890,118,0.49 [0.29-0.82],0.0064001547176645
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",28365,366,0.85 [0.64-1.14],0.2770811068247035
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",28339,403,0.91 [0.69-1.20],0.4948851875629902
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,28040,56,1.23 [0.58-2.61],0.5932213639060616
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,27856,56,1.11 [0.53-2.36],0.7769244160460954
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Transient ischemic attack,28205,147,0.63 [0.39-1.00],0.0493787998749814
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,27915,186,0.99 [0.66-1.49],0.9655140300392994
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Varicose veins,27546,327,1.06 [0.78-1.45],0.709191573499816
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,27810,49,0.59 [0.26-1.31],0.1955712340981343
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Venous thromboembolism,28431,548,1.36 [1.07-1.72],0.0128393041354127
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",28446,383,0.51 [0.38-0.67],2.859885500943712e-06
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",25520,1468,0.80 [0.69-0.93],0.0037964854232464
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Any mental disorder,27837,3785,0.82 [0.75-0.90],2.3217415451208115e-05
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",28380,455,0.43 [0.33-0.56],2.084046065114331e-10
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",25771,1719,0.79 [0.69-0.90],0.0006172602956423
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",24146,94,0.78 [0.44-1.39],0.3993766051731515
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Smoking dependency,28057,1564,0.83 [0.72-0.95],0.0089577571471403
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",25866,1814,0.73 [0.64-0.83],2.9143022610097377e-06
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Vascular dementia,28489,21,1.27 [0.38-4.26],0.6965040392731805
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Alzheimer disease,28609,67,1.81 [0.91-3.58],0.0911725097904177
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Bell's palsy,26898,76,0.70 [0.37-1.33],0.2780022693470664
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,27315,493,1.05 [0.81-1.36],0.7105341199690391
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Cerebral cysts,28242,211,0.66 [0.45-0.97],0.0364756037219624
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,28524,235,0.49 [0.34-0.71],0.0001519320512632
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,28463,24,1.60 [0.51-5.05],0.4249192129415841
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,28594,52,0.76 [0.35-1.67],0.4993559041720765
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",28092,61,0.37 [0.18-0.75],0.0061007254754068
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Epilepsy,26994,269,0.92 [0.65-1.30],0.6495589783264897
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,28114,1389,0.93 [0.80-1.08],0.324627886988293
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,28580,281,0.74 [0.53-1.03],0.0743671390379683
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Falls/tendency to fall,28073,1700,0.85 [0.74-0.98],0.022258122530268
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Generalized epilepsy,28224,54,0.73 [0.34-1.56],0.4111316307200681
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Hemiplegia,28457,168,0.57 [0.37-0.88],0.0105673922552122
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Hydrocephalus,28079,48,0.78 [0.35-1.76],0.555291639180161
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,28585,65,0.82 [0.41-1.64],0.5710522840959541
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,26904,82,0.94 [0.50-1.77],0.8471463187683906
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,26911,89,0.54 [0.30-0.98],0.0438907453759933
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Memory loss,28453,76,0.38 [0.20-0.71],0.0025233292998289
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Migraine,27165,440,0.98 [0.75-1.29],0.8832319558649446
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",28516,391,0.95 [0.72-1.27],0.7482500306171513
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Motor neuron disease,20855,100,0.68 [0.39-1.22],0.1957347674528529
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,28405,147,0.74 [0.46-1.18],0.2084843308843931
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",27986,1164,0.90 [0.76-1.06],0.1993161496059195
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Neurological diseases,27145,3175,0.87 [0.78-0.96],0.005060021405437
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,28515,76,0.71 [0.37-1.34],0.290616861113936
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",27215,393,0.91 [0.68-1.21],0.5194686387811749
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",28536,241,1.33 [0.93-1.90],0.1227268156192601
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,23881,314,0.86 [0.62-1.18],0.3467067794315686
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,28093,62,1.32 [0.65-2.70],0.4473748078284918
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other disorders of nervous system,28150,119,0.97 [0.58-1.63],0.9224221250386438
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,28392,93,0.93 [0.52-1.67],0.817563422973197
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other facial nerve disorders,26916,94,0.83 [0.47-1.49],0.5386496154312923
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other headache syndromes,26787,62,1.48 [0.72-3.03],0.2817264347444939
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other neurological diseases,28483,452,0.79 [0.61-1.04],0.0893775947958475
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other sleep disorders,27324,599,0.96 [0.76-1.21],0.7118626005360319
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Parkinson's disease,28596,165,0.70 [0.46-1.09],0.114399765145868
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,28097,66,0.81 [0.40-1.63],0.5494277362173212
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Restless leg syndrome,28608,48,1.39 [0.62-3.13],0.4217158815200597
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Sleep apnoea,28358,519,0.89 [0.69-1.13],0.3366599388017335
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Small fibre neuropathy,28332,37,1.20 [0.48-3.04],0.6985736230245884
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,28593,126,0.66 [0.40-1.10],0.1085976014770556
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,26854,32,0.56 [0.20-1.52],0.2513000707984835
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,28609,68,1.87 [0.95-3.69],0.0714298197186541
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),28476,20,1.23 [0.36-4.23],0.7449785680364456
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,28112,42,0.60 [0.25-1.43],0.2480204153788
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,28245,224,1.09 [0.75-1.59],0.6484363905877584
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,28516,198,1.92 [1.30-2.82],0.0010025674751744
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,27842,38,1.12 [0.45-2.81],0.8115731206475463
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,27881,77,1.14 [0.60-2.16],0.6970176370048027
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",28515,32,0.74 [0.27-2.01],0.5574273495981632
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,28401,65,0.80 [0.40-1.61],0.5343238630895661
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1732,44,6.55 [3.07-14.01],1.2357803050601524e-06
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2045,88,1.38 [0.79-2.40],0.2605533821828352
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,28149,79,1.23 [0.66-2.32],0.5147399713693492
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,28474,637,1.03 [0.82-1.28],0.8239592514093481
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",28295,491,1.14 [0.88-1.47],0.313423289257223
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,27943,139,1.26 [0.78-2.04],0.3451188970067008
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",28513,492,1.15 [0.89-1.49],0.2745134427839345
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,28596,55,0.91 [0.43-1.94],0.8063787983822404
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,28438,417,1.32 [1.00-1.74],0.0523407501614651
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",28564,228,0.93 [0.64-1.35],0.6991999002432014
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,28543,133,0.81 [0.50-1.32],0.3971576206666312
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,27821,17,1.09 [0.28-4.29],0.8981746292257666
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,27834,30,0.71 [0.26-1.99],0.5215441254208788
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,27836,32,1.83 [0.67-4.97],0.2353944492905943
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,28560,392,0.85 [0.64-1.13],0.2709302713576591
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,28270,102,0.75 [0.43-1.30],0.3044881357319193
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,28048,27,1.99 [0.67-5.93],0.2145459269226982
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,28412,76,1.02 [0.53-1.94],0.9598987009458008
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,28489,153,0.91 [0.58-1.44],0.6886114073531828
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,28188,167,1.42 [0.92-2.19],0.1182561849483091
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,28488,78,0.82 [0.43-1.55],0.5369174213059562
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,28428,260,0.98 [0.69-1.38],0.8880853664023303
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,28192,122,0.78 [0.47-1.29],0.3291893141429037
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,27874,1094,0.96 [0.81-1.14],0.6694060973471453
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,28462,126,0.82 [0.50-1.36],0.4448301987005101
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,28582,116,1.52 [0.90-2.55],0.113762164063938
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,28076,272,1.22 [0.87-1.72],0.2442076711124546
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,28374,38,1.31 [0.52-3.26],0.5651602956210606
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,28579,38,1.18 [0.47-2.93],0.723736440855729
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,27845,41,1.04 [0.43-2.53],0.9231412771057262
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,27924,120,1.26 [0.75-2.11],0.3843257207655055
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,27908,71,1.07 [0.55-2.08],0.8448648704715129
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,28081,60,0.56 [0.27-1.17],0.123704699250247
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",27889,52,0.53 [0.24-1.15],0.1081041135114232
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,28227,59,0.44 [0.21-0.92],0.0282956115463516
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",28261,93,0.92 [0.51-1.63],0.7650341647945313
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,27898,94,1.16 [0.65-2.07],0.6059050601093003
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,27963,126,0.60 [0.36-0.99],0.0455156018170765
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,27874,37,1.30 [0.52-3.26],0.5741279279141493
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,27637,857,1.10 [0.91-1.33],0.3427124473523578
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,27854,50,1.37 [0.62-3.06],0.4395047927221361
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,28385,315,0.82 [0.60-1.13],0.2216581624967495
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,28109,39,0.76 [0.31-1.86],0.549601524672215
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),28203,133,0.87 [0.54-1.42],0.5848737230307979
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,28407,63,0.74 [0.36-1.51],0.4126713371242017
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,28566,101,1.11 [0.63-1.95],0.7142607211918778
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,28483,143,0.83 [0.52-1.33],0.4359912091134384
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,28399,55,2.16 [1.02-4.58],0.0435916633577119
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,28400,56,1.59 [0.74-3.38],0.2324969038983511
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,28520,549,0.93 [0.73-1.19],0.581145032523009
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,28310,339,0.86 [0.63-1.17],0.3252384617012301
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,28071,100,0.88 [0.50-1.54],0.6432202280283281
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,28054,83,1.53 [0.82-2.83],0.1779342099568323
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Acute pharyngitis,28315,83,0.88 [0.48-1.64],0.6984890164456655
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,28471,239,1.16 [0.80-1.66],0.4317840300922466
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,28297,65,1.33 [0.66-2.66],0.4194147316301152
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,All influenza,27255,80,1.65 [0.88-3.10],0.1171926869181103
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),27253,78,1.62 [0.86-3.06],0.136978878999471
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Allergic asthma (mode),21213,132,0.72 [0.44-1.19],0.2006390531596346
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Allergic rhinitis,28452,320,0.83 [0.60-1.13],0.2355228260103486
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",22762,1826,0.83 [0.72-0.94],0.0048846470816128
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",22876,1795,0.84 [0.73-0.96],0.0094877694863789
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),28312,98,2.80 [1.61-4.88],0.0002601685871883
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",27234,59,3.66 [1.79-7.51],0.0003890797476421
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Bronchiectasis,25471,190,0.65 [0.43-0.97],0.0374354618698973
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",25325,44,0.85 [0.36-1.99],0.7089954510070533
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,27716,2435,0.82 [0.73-0.92],0.0005585452069992
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",27086,69,0.55 [0.28-1.08],0.0844632521458667
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Chronic sinusitis,27192,175,0.54 [0.35-0.83],0.0048999254903777
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",28501,739,0.73 [0.60-0.90],0.0026281453146431
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Deviated nasal septum,27150,133,0.98 [0.60-1.59],0.9205183784150274
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,26627,4403,0.90 [0.83-0.98],0.016538957249098
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",27406,389,0.74 [0.56-0.99],0.0418848278782156
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Early onset COPD,28283,521,0.72 [0.57-0.92],0.0091009532599951
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Emphysema,25471,190,0.70 [0.47-1.05],0.0827140535348567
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,27327,115,1.09 [0.64-1.84],0.7590220714596995
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Influenza and pneumonia,28418,1243,1.01 [0.86-1.19],0.8849608897866367
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Interstitial lung disease,27353,141,0.99 [0.62-1.60],0.9713532391506858
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Later onset COPD,27126,218,0.68 [0.47-0.99],0.0438139278657124
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,28600,160,0.79 [0.51-1.23],0.3054513880712218
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Nasal polyp,27135,118,0.91 [0.54-1.53],0.7134486434376317
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,28393,637,0.90 [0.72-1.13],0.3703897953291987
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other diseases of pleura,28428,1289,0.89 [0.76-1.04],0.1311549031241683
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,27931,914,0.79 [0.66-0.95],0.0135169436274851
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other pleural conditions,27174,35,2.47 [0.95-6.39],0.0629281072443977
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,28552,204,1.43 [0.96-2.11],0.0753940224404424
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,28525,876,0.89 [0.74-1.08],0.2364647474464698
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Pleural effusion,27755,616,0.99 [0.79-1.24],0.9025257279529167
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Pleural plaque,27196,57,0.68 [0.32-1.44],0.3153223900999444
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",28203,1028,0.93 [0.78-1.11],0.4470169299093443
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,28580,140,0.83 [0.52-1.33],0.4370568370059605
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Pneumothorax,27203,64,0.77 [0.38-1.57],0.4759530820247147
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Pollen allergy,28572,274,0.79 [0.56-1.11],0.1813638960567014
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Pulmonary oedema,28387,39,3.83 [1.63-9.02],0.0021303033938754
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Respiratory insufficiency,21119,38,0.59 [0.24-1.46],0.2540293309604064
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,28373,617,0.91 [0.73-1.15],0.4334946658649478
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,27337,320,0.82 [0.60-1.13],0.232397188753287
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Viral pneumonia,27372,197,0.98 [0.66-1.46],0.916132332305584
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",28332,170,1.06 [0.69-1.62],0.8034542218359728
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,16529,103,0.57 [0.33-1.00],0.0513023443501805
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,21926,68,0.99 [0.50-1.96],0.974176392834226
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Acute appendicitis,28405,161,1.10 [0.70-1.72],0.6840996664700805
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Acute gastritis,22870,76,1.02 [0.53-1.96],0.9533343924529004
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Acute pancreatitis,26966,170,0.70 [0.46-1.09],0.112136020485622
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Acute peritonitis,28158,76,4.39 [2.37-8.13],2.4894625319356425e-06
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Alcoholic liver disease,27804,87,0.50 [0.27-0.90],0.0215943046277435
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Barrett oesophagus,23157,363,0.97 [0.72-1.31],0.8578730939216398
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",26854,58,0.80 [0.38-1.66],0.5451553654849033
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",28189,58,0.81 [0.39-1.69],0.5693148503274843
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Cholecystitis,26984,188,0.86 [0.57-1.30],0.4808232423132154
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Cholelithiasis,27731,935,0.82 [0.68-0.98],0.0314019139477887
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Chronic gastritis,23058,264,0.89 [0.63-1.26],0.5009631254982456
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Chronic pancreatitis,26840,44,0.95 [0.41-2.20],0.8964162614279775
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",28457,83,1.09 [0.59-2.00],0.7900181745893202
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Coeliac disease,27134,122,0.95 [0.56-1.59],0.835023758079502
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Collagenous colitis,26991,62,1.03 [0.50-2.14],0.9273698946435996
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,28421,215,1.03 [0.70-1.51],0.889413454738889
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Constipation,28379,1208,0.92 [0.78-1.08],0.31461444171157
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Crohn disease,27025,96,1.50 [0.84-2.68],0.1691778345779594
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",28250,67,1.48 [0.74-2.95],0.2685250429850164
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Crohn's disease NAS,27023,94,2.27 [1.27-4.07],0.0058628043698996
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Dental caries,27735,271,0.79 [0.56-1.11],0.1760177226617789
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,26460,1886,0.86 [0.76-0.98],0.0276334162303905
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of appendix,28449,205,1.10 [0.74-1.63],0.6508613906468138
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of liver,28486,769,0.84 [0.68-1.03],0.0868929664863594
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",26845,4051,0.92 [0.85-1.01],0.0859730441973987
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",28101,637,0.99 [0.79-1.24],0.9184813406914308
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of peritoneum,28525,443,1.15 [0.88-1.50],0.3152632527433809
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,27600,136,1.14 [0.70-1.84],0.5981585940669842
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of salivary glands,27431,70,0.58 [0.30-1.12],0.1064244045302783
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of the digestive system,28321,1309,0.92 [0.78-1.07],0.2655899288981911
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of tongue,27444,125,1.50 [0.91-2.49],0.1118358933309597
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",28078,1282,0.82 [0.70-0.96],0.0141811553621078
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,24381,2523,0.86 [0.77-0.96],0.0074140315159199
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Duodenal ulcer,22943,149,1.03 [0.65-1.64],0.8978510377628283
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",28536,118,0.90 [0.54-1.50],0.6922533174051638
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,28466,84,1.02 [0.55-1.90],0.9451191721468976
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,27822,105,1.07 [0.62-1.83],0.8166300832016762
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,22045,187,0.94 [0.62-1.43],0.7838277641237458
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Functional dyspepsia,23325,531,1.03 [0.80-1.31],0.8367332032960213
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gastric ulcer,23087,293,0.89 [0.64-1.23],0.4764075797382338
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,25124,2330,0.82 [0.73-0.92],0.000716228657593
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,23216,422,0.92 [0.70-1.22],0.5696825237209373
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,23376,8374,0.90 [0.84-0.96],0.0007863667124029
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,GI-bleeding,28065,1053,0.86 [0.73-1.03],0.0982693686967677
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,27525,61,0.64 [0.31-1.32],0.2253497003376828
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,22813,1330,0.94 [0.80-1.10],0.4178349447014197
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",27774,57,1.43 [0.68-2.98],0.3420524788753727
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Hernia,27411,2837,0.86 [0.77-0.95],0.0044354166944146
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Impacted teeth,28476,78,1.12 [0.59-2.13],0.7351257293600759
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Impaction of intestines,21892,34,2.05 [0.78-5.37],0.1462430856299328
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Inguinal hernia,25276,702,0.74 [0.60-0.91],0.004631730099587
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",24656,82,0.96 [0.52-1.77],0.8964596721908746
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,21934,76,1.32 [0.69-2.53],0.4081778840717847
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Intestinal malabsorption,27155,143,1.12 [0.70-1.81],0.6353608650250087
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,22451,593,0.84 [0.67-1.06],0.1492564851753138
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,28584,399,0.83 [0.63-1.10],0.1937798560622836
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,27656,727,0.89 [0.72-1.10],0.2698394084854087
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,27849,920,0.89 [0.74-1.07],0.2149210604702142
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Oesophageal obstruction,22950,156,0.88 [0.56-1.39],0.5864808887291865
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Oesophagitis,23296,502,0.98 [0.76-1.26],0.8511480388715088
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,28565,138,0.88 [0.55-1.43],0.6183771494765913
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,24624,50,0.65 [0.29-1.44],0.2882395700704994
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,23195,1337,0.98 [0.84-1.14],0.76821610079082
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,26999,203,0.80 [0.54-1.19],0.2684614893545747
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,26966,170,0.81 [0.53-1.25],0.3480626262817174
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of intestine,23406,1548,0.88 [0.76-1.01],0.0761494334472293
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of intestines,26920,5062,0.91 [0.84-0.98],0.0192619155443205
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,27437,203,0.84 [0.57-1.26],0.4028289246054779
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of liver,28339,622,0.92 [0.73-1.15],0.4470624521174999
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,23353,559,0.87 [0.69-1.11],0.2671005111346122
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of pancreas,26882,86,0.95 [0.51-1.74],0.8623349671814766
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,28466,384,0.91 [0.68-1.22],0.5367558882537673
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,23599,805,0.79 [0.64-0.96],0.0193358003725549
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,28079,1067,0.88 [0.74-1.05],0.1530444316812473
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,27660,196,0.94 [0.63-1.41],0.7700969609508437
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,23114,1256,0.88 [0.75-1.03],0.1081513455155329
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),24649,1855,0.93 [0.82-1.06],0.3018139945480198
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,27803,86,0.93 [0.50-1.70],0.8063886935752547
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,27733,804,0.95 [0.78-1.16],0.6278005406915297
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",22098,240,0.76 [0.52-1.09],0.1342388746897677
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,28450,100,1.13 [0.64-2.00],0.6710862633030398
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,22217,359,1.01 [0.75-1.37],0.9360193854622242
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",27153,141,1.30 [0.81-2.09],0.2703795269727221
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Recurring oral aphthae,28599,59,1.53 [0.73-3.19],0.256114929103364
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,27480,132,1.22 [0.75-2.00],0.4211693582276175
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Toxic colitis,26961,32,3.32 [1.23-8.93],0.0175729331989277
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,22984,190,0.82 [0.54-1.23],0.3396648089148977
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Ulcerative colitis,27081,152,1.06 [0.67-1.68],0.8079182302634348
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",27061,132,0.94 [0.57-1.55],0.8123226265050683
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Umbilical hernia,24865,291,0.98 [0.71-1.36],0.908352329102919
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,21963,105,0.69 [0.40-1.20],0.1861627429157402
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Ventral hernia,24806,232,0.94 [0.65-1.36],0.744535626759286
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Volvulus,21923,65,1.55 [0.77-3.13],0.218419099510893
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,28553,167,0.94 [0.61-1.46],0.7864329942679184
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,28331,77,0.71 [0.37-1.35],0.3010128751114934
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,27074,152,0.57 [0.36-0.91],0.0184586271105454
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,27970,572,1.08 [0.86-1.37],0.5087646895865682
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",27601,203,0.88 [0.59-1.31],0.5296455595672019
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,27104,182,0.56 [0.37-0.85],0.0067707112782871
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,28341,236,0.95 [0.66-1.37],0.7795502974522704
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,28508,403,0.86 [0.65-1.14],0.2826286409292932
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,28154,49,0.58 [0.26-1.30],0.1858692717410221
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,27096,2668,0.88 [0.79-0.99],0.0272544997390201
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,28136,459,0.62 [0.47-0.80],0.000316918941732
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,28005,328,0.63 [0.46-0.87],0.0041902723325644
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,28210,812,1.00 [0.82-1.21],0.9725808063097388
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",28597,48,0.68 [0.30-1.56],0.3688618752950436
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,26978,56,1.44 [0.68-3.07],0.3417373255520938
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,27719,42,0.65 [0.27-1.55],0.3342063420097045
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,28334,229,1.00 [0.69-1.45],0.992940622461688
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,27222,300,1.06 [0.76-1.47],0.7437759571780064
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,26960,38,1.29 [0.52-3.21],0.5891156923160268
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,28523,70,1.28 [0.66-2.50],0.468506893022274
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,27538,140,0.65 [0.40-1.05],0.0755599267917049
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,28413,159,0.63 [0.40-0.98],0.0402041942170672
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,28138,33,0.74 [0.28-1.95],0.5372570115336546
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,26977,55,0.64 [0.30-1.38],0.2567482943931173
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,28066,1144,0.91 [0.77-1.08],0.2957568477757673
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",27253,331,1.12 [0.82-1.54],0.463096734717236
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,26964,42,0.90 [0.38-2.16],0.8219494774351044
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,28523,269,0.70 [0.50-0.99],0.0462019307149645
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,28168,63,1.45 [0.72-2.93],0.2978177920845892
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,28475,221,0.72 [0.49-1.05],0.0836853868070935
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,28576,190,0.99 [0.65-1.50],0.95556865093512
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,27048,126,0.61 [0.36-1.01],0.0567555276806928
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,27121,199,1.10 [0.73-1.64],0.6569863191147299
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,28567,181,1.02 [0.67-1.56],0.9262455956971016
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",27058,136,0.59 [0.37-0.95],0.0303802592783257
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,28575,122,1.46 [0.88-2.43],0.1460617268765074
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,25122,139,0.81 [0.50-1.31],0.3865210897606594
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,26716,4821,0.95 [0.87-1.03],0.1820881660124448
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,25305,3410,0.94 [0.86-1.04],0.2485235787220689
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,25082,99,0.70 [0.39-1.23],0.2148596063287177
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,25692,161,1.09 [0.70-1.70],0.6987845627591993
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,25695,164,1.39 [0.90-2.16],0.1421824898188266
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,28376,119,1.42 [0.85-2.36],0.1833297351569987
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",25579,48,0.39 [0.17-0.87],0.0217295205829447
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,22668,773,0.92 [0.75-1.13],0.4137877907178184
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",28547,129,1.15 [0.70-1.89],0.5915413635388139
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,25832,301,0.75 [0.54-1.04],0.0836708777182863
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,25025,6462,0.92 [0.86-0.99],0.0194737864452944
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,27197,112,0.82 [0.48-1.40],0.467886591025472
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,25103,120,0.82 [0.49-1.36],0.43717166109851
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,25613,630,1.20 [0.96-1.51],0.1132239362806362
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,27689,2158,0.85 [0.75-0.96],0.0076678794102196
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,25217,234,1.07 [0.74-1.56],0.7130670210626816
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,25272,289,0.95 [0.68-1.33],0.7579026056949908
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,25136,153,1.30 [0.82-2.06],0.2698092013833686
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,28078,37,1.07 [0.41-2.74],0.8940627273645855
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,23263,1368,0.92 [0.79-1.07],0.2658440057646244
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,22303,408,0.93 [0.71-1.23],0.628447909738936
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",28554,398,0.93 [0.70-1.23],0.6234492301247794
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,21969,74,1.27 [0.65-2.47],0.4885153242762021
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),22254,359,1.09 [0.81-1.48],0.5627976125836536
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,25326,343,0.76 [0.56-1.04],0.0858018399937695
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,22694,799,1.12 [0.92-1.37],0.2685074879457151
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,25561,30,0.72 [0.25-2.02],0.5281744869173657
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,26101,570,0.89 [0.70-1.12],0.3116659281661176
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,25819,288,0.83 [0.59-1.16],0.2658987418959749
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,22639,744,1.16 [0.94-1.43],0.1646709108674525
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,25072,89,1.00 [0.55-1.83],0.992401271505719
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",25047,64,1.02 [0.50-2.07],0.963613351105838
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,27145,60,0.78 [0.38-1.59],0.4939637270190945
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,28265,1180,1.12 [0.95-1.32],0.1914625564646941
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,27752,667,1.20 [0.97-1.50],0.0991164212473695
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",28497,355,0.89 [0.66-1.19],0.4261083191844015
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,23726,1831,0.97 [0.85-1.10],0.610182324350139
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,21979,84,1.12 [0.60-2.08],0.732551333464156
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,25063,80,1.08 [0.57-2.04],0.8107617443994943
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,21922,27,1.30 [0.44-3.87],0.6378548822108225
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),22011,116,0.79 [0.46-1.35],0.382759288168208
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,27322,237,1.16 [0.81-1.68],0.4151550359688772
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,27334,249,1.22 [0.85-1.75],0.2874088387628371
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,28567,87,0.64 [0.35-1.17],0.1443145822752808
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",27143,1612,0.93 [0.81-1.07],0.3258747739737262
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,25108,125,0.91 [0.55-1.52],0.7194993703322907
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),22018,123,0.85 [0.50-1.43],0.5364894064371729
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,26184,653,0.99 [0.79-1.24],0.942360806018936
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,24016,2121,1.01 [0.89-1.15],0.848687210230134
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,28100,59,1.07 [0.51-2.26],0.8487858203955337
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,28582,74,0.76 [0.40-1.47],0.4162122291997113
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,25068,85,0.52 [0.28-0.96],0.0354629530341815
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",26121,1138,1.08 [0.92-1.28],0.3537611849807343
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,25054,71,0.81 [0.41-1.58],0.5298701591471169
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,23047,1152,0.85 [0.72-1.01],0.0576264426527855
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,27190,105,0.96 [0.55-1.67],0.8904541976863677
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,25054,71,2.12 [1.08-4.18],0.0293843379897161
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,25651,120,0.58 [0.34-0.97],0.0382001441671432
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,25400,417,1.31 [1.00-1.73],0.0528933988153105
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,28258,217,0.85 [0.58-1.26],0.42724062557634
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,26010,479,1.15 [0.89-1.49],0.2734468908547577
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,28506,335,0.89 [0.66-1.21],0.4707080412626285
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,28591,39,0.40 [0.16-0.99],0.0470262663876779
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,25197,214,0.90 [0.61-1.32],0.5836331760654105
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,22976,618,1.01 [0.80-1.27],0.9459426576526468
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,25500,517,1.10 [0.86-1.41],0.4618000600190339
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],25160,177,1.04 [0.67-1.59],0.8719350973919368
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",21932,37,0.61 [0.24-1.53],0.2909255745205183
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,23714,1819,0.80 [0.70-0.92],0.0012044583181137
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,22363,468,0.82 [0.63-1.07],0.1439084202278305
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,28129,88,0.91 [0.49-1.68],0.762648650464494
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",28532,52,0.55 [0.25-1.20],0.1341329606247569
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",26940,31,1.96 [0.72-5.32],0.185037828201398
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,21971,76,0.70 [0.36-1.33],0.2746497817182914
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,25625,94,0.86 [0.48-1.54],0.6058710585012854
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,22254,359,0.82 [0.61-1.11],0.1966100030123596
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,25263,280,0.85 [0.61-1.19],0.3452913227883317
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,25752,221,1.01 [0.69-1.48],0.9657688018591024
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,25639,108,0.54 [0.31-0.93],0.0260993191180615
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,24244,48,0.61 [0.27-1.37],0.2305913673123551
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",28594,42,0.46 [0.19-1.09],0.0763667582841038
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,25611,628,0.83 [0.66-1.04],0.1111404559823073
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],28132,91,0.89 [0.49-1.63],0.7143303379076746
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,27481,2498,1.02 [0.91-1.15],0.6780807385207561
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",25096,113,0.94 [0.55-1.60],0.8176300762910154
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,25895,364,1.18 [0.87-1.58],0.2842677573405504
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,27174,192,0.53 [0.35-0.79],0.002037030621817
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,25687,156,1.10 [0.70-1.73],0.6842615052855952
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,26620,1089,0.94 [0.79-1.11],0.448546313185166
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,26255,724,1.08 [0.88-1.33],0.4727793052393768
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],25029,46,0.82 [0.36-1.88],0.6369341223747004
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,28191,150,0.62 [0.39-0.99],0.0446197070536173
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,25146,163,1.51 [0.97-2.36],0.0690781457366699
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,25044,61,1.65 [0.80-3.43],0.1771269853224299
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),21934,39,0.51 [0.21-1.26],0.1462210781679569
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Acute renal failure,28030,889,1.51 [1.25-1.82],2.2440699041829025e-05
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),11624,76,1.17 [0.61-2.25],0.644138076377097
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,15443,78,1.18 [0.61-2.26],0.6192268357229619
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,28301,336,0.92 [0.68-1.25],0.5807093437712829
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,28027,62,0.69 [0.34-1.40],0.3024882945465794
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,27856,715,5.00 [4.07-6.16],3.3571463103823454e-52
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,28414,33,12.87 [5.47-30.24],4.63815321753638e-09
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,28426,194,1.23 [0.82-1.85],0.3077230897409112
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Cystitis,26317,167,0.56 [0.37-0.87],0.01028660804186
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Dialysis,27200,59,2.18 [1.61-2.96],4.991400721509424e-07
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,12365,1170,1.05 [0.89-1.24],0.5616936199148412
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Disorders of breast,15574,209,1.13 [0.76-1.69],0.5376022651263539
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Endometriosis,11691,143,1.26 [0.78-2.03],0.3383022252791812
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",11944,396,0.77 [0.58-1.03],0.0780036516868382
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,11985,437,0.73 [0.56-0.96],0.0252594218765236
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,24139,4430,1.04 [0.95-1.13],0.3885976489234106
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,28451,70,4.66 [2.43-8.92],3.4903259429502165e-06
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Hydrocele,11285,90,0.61 [0.34-1.10],0.100612235445105
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,27055,236,1.21 [0.84-1.76],0.3123756572624863
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,11969,774,1.08 [0.88-1.32],0.4610114731755484
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,15426,249,0.84 [0.59-1.21],0.3623898265230718
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),11303,108,0.71 [0.41-1.21],0.2053233776344644
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Irregular menses,15440,130,0.68 [0.41-1.13],0.1399848450150226
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Menorrhagia,11851,303,0.81 [0.58-1.12],0.2051888190771922
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,26220,70,0.72 [0.37-1.42],0.3422620064276085
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,13008,1460,0.85 [0.73-0.99],0.0327732299560991
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,11244,49,0.50 [0.23-1.11],0.0879072113546943
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,11653,105,0.86 [0.49-1.51],0.6060114712400351
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",28597,41,0.59 [0.25-1.42],0.2407986303584657
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",28604,48,0.31 [0.14-0.67],0.0031235433082923
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,27715,1565,0.96 [0.83-1.11],0.569530954935074
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,26640,490,0.92 [0.71-1.18],0.4968888054584888
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,15434,69,0.94 [0.47-1.88],0.8585462292721823
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,28557,325,1.52 [1.11-2.08],0.0081811633257382
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,11353,158,0.95 [0.61-1.49],0.8364301908047398
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,11317,122,0.85 [0.51-1.41],0.5284166540955126
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,11274,79,0.87 [0.46-1.62],0.6534697882780605
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,28571,53,0.50 [0.23-1.10],0.0858659748511137
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,27282,1132,1.03 [0.87-1.22],0.6998593169791254
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,15306,129,0.84 [0.51-1.39],0.5055104564080412
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,11638,90,0.54 [0.29-0.98],0.0427059891650873
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",11784,236,0.93 [0.64-1.34],0.693378277491536
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,11610,62,0.99 [0.48-2.04],0.9702909358028728
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,11654,106,0.65 [0.38-1.14],0.1311098151766813
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,27089,270,1.40 [0.99-1.99],0.0572207964057194
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,28347,115,1.67 [0.99-2.82],0.0550940183884998
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,11738,190,0.88 [0.58-1.33],0.5356581391192949
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,11632,84,0.63 [0.34-1.19],0.1539395511909521
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,11994,446,0.85 [0.65-1.11],0.2402583368904638
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,11616,68,0.86 [0.43-1.72],0.6682499451925914
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,11938,390,0.78 [0.59-1.04],0.091390924728882
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,28430,49,1.80 [0.81-3.98],0.1502065897305702
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",11305,110,1.04 [0.61-1.77],0.8843757293417858
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,28399,1580,1.76 [1.52-2.03],8.526287991550188e-15
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",26964,145,1.56 [0.97-2.51],0.0680178562723325
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,27221,80,6.99 [3.76-13.00],7.943685233579346e-10
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,28040,75,0.99 [0.52-1.88],0.9647005730168604
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Urethral stricture,26323,173,1.03 [0.67-1.58],0.8986453079799481
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Urolithiasis,28366,401,0.92 [0.69-1.21],0.5424247005927826
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Uterine polyps,11656,108,0.76 [0.44-1.31],0.3212736484416331
